OnabotulinumtoxinA in the treatment of neurogenic bladder

References

• GerridzenRGThijssenAMDehouxERisk factors for upper tract deterioration in chronic spinal cord injury patientsJ Urol199214724164181732606
   PubMed Web of Science ®Google Scholar
• BurnsASRivasDADitunnoJFThe management of neurogenic bladder and sexual dysfunction after spinal cord injurySpine (Phila Pa)197626Suppl 24S129S136
   Google Scholar
• HacklerRHA 25-year prospective mortality study in the spinal cord injured patient: comparison with the long-term living paraplegicJ Urol19771174486488850323
   PubMed Web of Science ®Google Scholar
• LidalIBSnekkevikHAamodtGHjeltnesNBiering-SorensenFStanghelleJKMortality after spinal cord injury in NorwayJ Rehabil Med200739214515117351697
   PubMed Web of Science ®Google Scholar
• PannekJStohrerMBlokBGuidelines on Neurogenic Lower Urinary Tract DysfunctionArnhem, The NetherlandsEuropean Association of Urology2011
   Google Scholar
• MarrieRACutterGTyryTVollmerTCampagnoloDDisparities in the management of multiple sclerosis-related bladder symptomsNeurology200768231971197817548546
   PubMed Web of Science ®Google Scholar
• SatarNBauerSBShefnerJKellyMDDarbeyMMThe effects of delayed diagnosis and treatment in patients with an occult spinal dysraphismJ Urol19951542 Pt 27547587609171
   PubMed Web of Science ®Google Scholar
• MadersbacherHThe various types of neurogenic bladder dysfunction: an update of current therapeutic conceptsParaplegia19902842172292235029
   PubMedGoogle Scholar
• RickwoodAMAssessment and conservative management of the neuropathic bladderSemin Pediatr Surg200211210811911973763
   PubMedGoogle Scholar
• MadhuvrataPSinghMHasafaZAbdel-FattahMAnticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysisEur Urol2252012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• ChancellorMBAndersonRUBooneTBPharmacotherapy for neurogenic detrusor overactivityAm J Phys Med Rehabil200685653654516715024
   PubMed Web of Science ®Google Scholar
• StohrerMPannekJSurgery to improve reservoir functionCorcosJSchickETextbook of the Neuropathic Bladder2nd edLondon, UKInforma Healthcare2008
   Google Scholar
• LinsenmeyerTAHortonJBeneventoJImpact of alpha1-blockers in men with spinal cord injury and upper tract stasisJ Spinal Cord Med200225212412812137216
   PubMedGoogle Scholar
• TalbotHSMahoneyEMJaffeeSRThe effects of prolonged urethral catheterization. I. Persistence of normal renal structure and functionJ Urol195981113814513631789
   PubMed Web of Science ®Google Scholar
• McClurgDAsheRGMarshallKLowe-StrongASComparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot studyNeurourol Urodyn200625433734816637070
   PubMed Web of Science ®Google Scholar
• GreenwellTJVennSNMundyARAugmentation cystoplastyBJU Int200188651152511678743
   PubMed Web of Science ®Google Scholar
• KhastgirJHamidRAryaMShahNShahPJSurgical and patient reported outcomes of ‘clam’ augmentation ileocystoplasty in spinal cord injured patientsEur Urol200343326326912600429
   PubMed Web of Science ®Google Scholar
• SchmidtRATanaghoEAFeasibility of controlled micturition through electric stimulationUrol Int1979343199230382559
   PubMed Web of Science ®Google Scholar
• ChaabaneWGuillotreauJCastel-LacanalESacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic studyNeurourol Urodyn201130454755021488095
   PubMed Web of Science ®Google Scholar
• BennettJKGreenBGFooteJEGrayMCollagen injections for intrinsic sphincter deficiency in the neuropathic urethraParaplegia199533126977008927407
   PubMedGoogle Scholar
• ChartierKEGenevoisSGameXTreatment of neurogenic male urinary incontinence related to intrinsic sphincter insufficiency with an artificial urinary sphincter: a French retrospective multicentre studyBJU Int2011107342643220633005
   PubMed Web of Science ®Google Scholar
• ReynardJMVassJSullivanMEMamasMSphincterotomy and the treatment of detrusor-sphincter dyssynergia: current status, future prospectsSpinal Cord200341111112494314
   PubMed Web of Science ®Google Scholar
• PistolesiDSelliCRossiBStampacchiaGBotulinum toxin type B for type A resistant bladder spasticityJ Urol20041712 Pt 180280314713821
   PubMed Web of Science ®Google Scholar
• DykstraDDSidiAAScottABPagelJMGoldishGDEffects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patientsJ Urol198813959199223361663
   PubMed Web of Science ®Google Scholar
• SchurchBSchmidDMStohrerMTreatment of neurogenic incontinence with botulinum toxin AN Engl J Med2000342966510702067
   PubMed Web of Science ®Google Scholar
• KuoHCUrodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agentsUrology200463586887215134967
   PubMed Web of Science ®Google Scholar
• MariaGBrisindaGCivelloIMBentivoglioARSgangaGAlbaneseARelief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled studyUrology200362225926412893330
   PubMed Web of Science ®Google Scholar
• MontecuccoCMolgoJBotulinal neurotoxins: revival of an old killerCurr Opin Pharmacol20055327427915907915
   PubMed Web of Science ®Google Scholar
• ApostolidisAPopatRYiangouYDecreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivityJ Urol2005174397798216094018
   PubMed Web of Science ®Google Scholar
• LawrenceGWAokiKRDollyJOExcitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin a consistent with co-release of transmitters from efferent fibersJ Pharmacol Exp Ther201033431080108620576797
   PubMed Web of Science ®Google Scholar
• MangeraAAnderssonKEApostolidisAContemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)Eur Urol201160478479521782318
   PubMed Web of Science ®Google Scholar
• ReitzAStohrerMKramerGEuropean experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivityEur Urol200445451051515041117
   PubMed Web of Science ®Google Scholar
• GiannantoniADi StasiSMStephenRLBiniVCostantiniEPorenaMIntravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized studyJ Urol2004172124024315201783
   PubMed Web of Science ®Google Scholar
• SchurchBde SèzeMDenysPBotox Detrusor Hyperreflexia Study TeamBotulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month studyJ Urol2005174119620015947626
   PubMed Web of Science ®Google Scholar
• SchurchBDenysPKozmaCMReesePRSlatonTBarronRLBotulinum toxin A improves the quality of life of patients with neurogenic urinary incontinenceEur Urol200752385085817467889
   PubMed Web of Science ®Google Scholar
• CruzFHerschornSAliottaPEfficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo- controlled trialEur Urol201160474275021798658
   PubMed Web of Science ®Google Scholar
• GinsbergDGousseAKeppenneVPhase 3 efficacy and safety study of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity. [Abstract]Presented at the 2011 Annual Meeting of the American Urological AssociationMay 14–19, 2011Washington, DC
   Google Scholar
• HerschornSGajewskiJEthansKEfficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trialJ Urol201118562229223521497851
   PubMed Web of Science ®Google Scholar
• ApostolidisAMouradSThompsonCYanXHaag-MolkentellerCA dose-exploration study of the efficacy and safety of onabotulinumtoxina in patients with urinary incontinence due to neurogenic detrusor overactivityInternational Continence Society meetingAugust 29–September 2, 2011Glasgow, Scotland
   Google Scholar
• Abdel-MeguidTABotulinum toxin-A injections into neurogenic overactive bladder – to include or exclude the trigone? A prospective, randomized, controlled trialJ Urol201018462423242820952003
   PubMed Web of Science ®Google Scholar
• de SèzeMPetitHGallienPBotulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord diseaseEur Urol2002421566212121731
   PubMed Web of Science ®Google Scholar
• GallienPReymannJMAmarencoGNicolasBde SèzeMBellissantEPlacebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patientsJ Neurol Neurosurg Psychiatry200576121670167616291892
   PubMed Web of Science ®Google Scholar
• KuoHCSatisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesionNeurourol Urodyn200827879379618508331
   PubMed Web of Science ®Google Scholar
• WyndaeleJJVan DrommeSAMuscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivitySpinal Cord2002401159960012411968
   PubMed Web of Science ®Google Scholar
• De LaetKWyndaeleJJAdverse events after botulinum A toxin injection for neurogenic voiding disordersSpinal Cord200543739739915741978
   PubMed Web of Science ®Google Scholar
• PannekJGockingKBerschULong-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunctionBJU Int200910491246125019426192
   PubMed Web of Science ®Google Scholar
• KalsiVGonzalesGPopatRBotulinum injections for the treatment of bladder symptoms of multiple sclerosisAnn Neurol200762545245717890635
   PubMed Web of Science ®Google Scholar
• BauerRMGratzkeCRoosenAPatient-reported side effects of intradetrusor botulinum toxin type A for idiopathic overactive bladder syndromeUrol Int2011861687220639617
   PubMed Web of Science ®Google Scholar
• StoehrerMWolffAKramerGTreatment of neurogenic detrusor overactivity with botulinum toxin A: the first seven yearsUrol Int200983437938519996642
   PubMed Web of Science ®Google Scholar
• WhiteneckGMeadeMADijkersMTateDGBushnikTForchheimerMBEnvironmental factors and their role in participation and life satisfaction after spinal cord injuryArch Phys Med Rehabil200485111793180315520974
   PubMed Web of Science ®Google Scholar
• KhanSGameXKalsiVLong-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosisJ Urol201118541344134921334639
   PubMed Web of Science ®Google Scholar
• SahaiAKhanMSLe GallNDasguptaPGKT Botulinum Study GroupUrodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladderUrology200871345545918342186
   PubMed Web of Science ®Google Scholar
• ComperatEReitzADelcourtACapronFDenysPChartier-KastlerEHistologic features in the urinary bladder wall affected from neurogenic overactivity – a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type AEur Urol20065051058106416517054
   PubMed Web of Science ®Google Scholar
• ApostolidisAJacquesTSFreemanAHistological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivityEur Urol20085361245125318343564
   PubMed Web of Science ®Google Scholar
• Schulte-BauklohHBigalkeHMillerKBotulinum neurotoxin type A in urology: antibodies as a cause of therapy failureInt J Urol200815540741518452456
   PubMed Web of Science ®Google Scholar
• PistolesiDGiannariniGStampacchiaGSelliCShould we stop using botulinum neurotoxin type a in patients with neurogenic detrusor overactivity after development of secondary resistance?Eur Urol201160487287321802198
   PubMed Web of Science ®Google Scholar
• Del PopoloGFilocamoMTLi MarziVNeurogenic detrusor overactivity treated with English botulinum toxin a: 8-year experience of one single centreEur Urol20085351013101917950989
   PubMed Web of Science ®Google Scholar
• SahaiADowsonCKhanMSDasguptaPRepeated injections of botulinum toxin-A for idiopathic detrusor overactivityUrology201075355255820035984
   PubMed Web of Science ®Google Scholar